Cash Flow from Operating Activities: A company's cash flows from operations.
Sernova Biotherapeutics Inc. (SEOVF) had Cash Flow from Operating Activities of $-7.79M for the most recently reported fiscal year, ending 2025-10-31.
| Income Statement Financials | |
-- |
|
$-11.24M |
|
-- |
|
-- |
|
$10.72M |
|
$-10.72M |
|
$-0.51M |
|
$-11.23M |
|
$-11.23M |
|
$-11.23M |
|
$-11.23M |
|
$-11.24M |
|
$-11.23M |
|
$-10.72M |
|
$-10.48M |
|
328.29M |
|
328.29M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$0.37M |
|
$0.01M |
|
$0.17M |
|
$0.55M |
|
$17.70M |
|
$0.74M |
|
$0.74M |
|
$18.45M |
|
$-17.90M |
|
$-17.90M |
|
$-17.90M |
|
332.86M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-7.79M |
$0.02M |
|
$3.67M |
|
$4.29M |
|
$0.19M |
|
$-4.10M |
|
$1.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-0.04 |
|
-0.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
62.71% |
|
62.71% |
|
-2057.56% |
|
65.43% |
|
$-0.05 |
|
$-0.02 |
|
$-0.02 |
|